News and Updates

Without relying on controversial embryonic stem cells, a vaccine has been developed that appears to help patients with multiple sclerosis. The vaccine’s results were reported in early testing and was developed by scientists in Canada. This breakthrough could potentially lead to greater treatment leverage for patients with multiple sclerosis without conflicting with the views of pro-life advocates who oppose the use of the embryonic cells because days-old unborn children must be destroyed to get them.

A new vaccine for multiple sclerosis moves another step away from embryonic stem cells.